These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 12366601)

  • 1. Inflammatory bio-markers and cardiovascular risk prediction.
    Blake GJ; Ridker PM
    J Intern Med; 2002 Oct; 252(4):283-94. PubMed ID: 12366601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
    Ridker PM; Hennekens CH; Buring JE; Rifai N
    N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inflammatory markers and cytokines in cardiovascular disease].
    Ogiwara F; Takahashi M; Ikeda U
    Rinsho Byori; 2004 Aug; 52(8):686-92. PubMed ID: 15478624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel clinical markers of vascular wall inflammation.
    Blake GJ; Ridker PM
    Circ Res; 2001 Oct; 89(9):763-71. PubMed ID: 11679405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and other inflammatory risk markers in acute coronary syndromes.
    Blake GJ; Ridker PM
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):37S-42S. PubMed ID: 12644339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [C-reactive protein: cardiovascular issues of an acute-phase protein].
    Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
    Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker.
    Jialal I; Devaraj S
    Am J Clin Pathol; 2001 Dec; 116 Suppl():S108-15. PubMed ID: 11993695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory biomarkers in coronary artery disease.
    Zakynthinos E; Pappa N
    J Cardiol; 2009 Jun; 53(3):317-33. PubMed ID: 19477372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members.
    Di Napoli M; Schwaninger M; Cappelli R; Ceccarelli E; Di Gianfilippo G; Donati C; Emsley HC; Forconi S; Hopkins SJ; Masotti L; Muir KW; Paciucci A; Papa F; Roncacci S; Sander D; Sander K; Smith CJ; Stefanini A; Weber D
    Stroke; 2005 Jun; 36(6):1316-29. PubMed ID: 15879341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein: a new golden marker of cardiovascular risk.
    Gomes MC
    Rev Port Cardiol; 2002 Nov; 21(11):1329-46. PubMed ID: 12564084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein: risk marker or mediator in atherothrombosis?
    Jialal I; Devaraj S; Venugopal SK
    Hypertension; 2004 Jul; 44(1):6-11. PubMed ID: 15148294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein: a novel marker of cardiovascular risk.
    Shah SH; Newby LK
    Cardiol Rev; 2003; 11(4):169-79. PubMed ID: 12852794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein, cytokines and inflammation in cardiovascular diseases.
    Bucova M; Bernadic M; Buckingham T
    Bratisl Lek Listy; 2008; 109(8):333-40. PubMed ID: 18837239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper.
    Biasucci LM; ;
    Circulation; 2004 Dec; 110(25):e560-7. PubMed ID: 15611382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
    Krintus M; Kozinski M; Kubica J; Sypniewska G
    Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.
    Dandona P
    Mayo Clin Proc; 2008 Mar; 83(3):333-42. PubMed ID: 18316001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of C-reactive protein in cardiovascular disease risk.
    Albert MA; Ridker PM
    Curr Cardiol Rep; 1999 Jul; 1(2):99-104. PubMed ID: 10980827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.